Literature DB >> 21709155

A critical role for granzymes in antigen cross-presentation through regulating phagocytosis of killed tumor cells.

Sabine Hoves1, Vivien R Sutton, Nicole M Haynes, Edwin D Hawkins, Daniel Fernández Ruiz, Nikola Baschuk, Karin A Sedelies, Maximilian Schnurr, John Stagg, Daniel M Andrews, Jose A Villadangos, Joseph A Trapani.   

Abstract

Granzymes A and B (GrAB) are known principally for their role in mediating perforin-dependent death of virus-infected or malignant cells targeted by CTL. In this study, we show that granzymes also play a critical role as inducers of Ag cross-presentation by dendritic cells (DC). This was demonstrated by the markedly reduced priming of naive CD8(+) T cells specific for the model Ag OVA both in vitro and in vivo in response to tumor cells killed in the absence of granzymes. Reduced cross-priming was due to impairment of phagocytosis of tumor cell corpses by CD8α(+) DC but not CD8α(-) DC, demonstrating the importance of granzymes in inducing the exposure of prophagocytic "eat-me" signals on the dying target cell. Our data reveal a critical and previously unsuspected role for granzymes A and B in dictating immunogenicity by influencing the mode of tumor cell death and indicate that granzymes contribute to the efficient generation of immune effector pathways in addition to their well-known role in apoptosis induction.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21709155     DOI: 10.4049/jimmunol.1001670

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

Review 1.  Perforin and granzymes: function, dysfunction and human pathology.

Authors:  Ilia Voskoboinik; James C Whisstock; Joseph A Trapani
Journal:  Nat Rev Immunol       Date:  2015-06       Impact factor: 53.106

Review 2.  T Cells and Regulated Cell Death: Kill or Be Killed.

Authors:  Johan Spetz; Adam G Presser; Kristopher A Sarosiek
Journal:  Int Rev Cell Mol Biol       Date:  2018-08-29       Impact factor: 6.813

Review 3.  Increasing the efficacy of tumor cell vaccines by enhancing cross priming.

Authors:  Brian M Andersen; John R Ohlfest
Journal:  Cancer Lett       Date:  2012-07-16       Impact factor: 8.679

4.  Whole genome sequencing of Guzerá cattle reveals genetic variants in candidate genes for production, disease resistance, and heat tolerance.

Authors:  Izinara C Rosse; Juliana G Assis; Francislon S Oliveira; Laura R Leite; Flávio Araujo; Adhemar Zerlotini; Angela Volpini; Anderson J Dominitini; Beatriz C Lopes; Wagner A Arbex; Marco A Machado; Maria G C D Peixoto; Rui S Verneque; Marta F Martins; Roney S Coimbra; Marcos V G B Silva; Guilherme Oliveira; Maria Raquel S Carvalho
Journal:  Mamm Genome       Date:  2016-11-16       Impact factor: 2.957

5.  Antigen cross-presentation by dendritic cell subsets: one general or all sergeants?

Authors:  Stefan Nierkens; Jurjen Tel; Edith Janssen; Gosse J Adema
Journal:  Trends Immunol       Date:  2013-03-27       Impact factor: 16.687

6.  RIG-I-like helicases induce immunogenic cell death of pancreatic cancer cells and sensitize tumors toward killing by CD8(+) T cells.

Authors:  P Duewell; A Steger; H Lohr; H Bourhis; H Hoelz; S V Kirchleitner; M R Stieg; S Grassmann; S Kobold; J T Siveke; S Endres; M Schnurr
Journal:  Cell Death Differ       Date:  2014-07-11       Impact factor: 15.828

7.  B-CLL cells acquire APC- and CTL-like phenotypic characteristics after stimulation with CpG ODN and IL-21.

Authors:  Magdalena Hagn; Sue E Blackwell; Thamara Beyer; Verena Ebel; Dorit Fabricius; Stefanie Lindner; Stefan Stilgenbauer; Thomas Simmet; Constantine Tam; Paul Neeson; Joseph A Trapani; Hubert Schrezenmeier; George J Weiner; Bernd Jahrsdörfer
Journal:  Int Immunol       Date:  2014-02-04       Impact factor: 4.823

8.  A novel role for granzymes in anti-tumor immunity.

Authors:  Sabine Hoves; Vivien R Sutton; Joseph A Trapani
Journal:  Oncoimmunology       Date:  2012-03-01       Impact factor: 8.110

Review 9.  Antitumor immune responses mediated by dendritic cells: How signals derived from dying cancer cells drive antigen cross-presentation.

Authors:  Lotte Spel; Jaap-Jan Boelens; Stefan Nierkens; Marianne Boes
Journal:  Oncoimmunology       Date:  2013-10-21       Impact factor: 8.110

10.  How does ionizing irradiation contribute to the induction of anti-tumor immunity?

Authors:  Yvonne Rubner; Roland Wunderlich; Paul-Friedrich Rühle; Lorenz Kulzer; Nina Werthmöller; Benjamin Frey; Eva-Maria Weiss; Ludwig Keilholz; Rainer Fietkau; Udo S Gaipl
Journal:  Front Oncol       Date:  2012-07-25       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.